Colgate-Palmolive (NYSE:CL – Get Free Report)‘s stock had its “hold” rating reissued by Argus in a report issued on Thursday, Marketbeat.com reports.
Other equities research analysts also recently issued reports about the company. Bank of America cut their target price on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a research report on Monday, November 3rd. Citigroup lowered their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. Finally, Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target on the stock in a research note on Tuesday. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $89.00.
Check Out Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Stock Up 0.9%
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.Colgate-Palmolive’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 earnings per share. On average, equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Colgate-Palmolive
A number of institutional investors have recently made changes to their positions in the stock. Brighton Jones LLC boosted its position in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the period. Klingman & Associates LLC raised its stake in shares of Colgate-Palmolive by 4.3% during the 1st quarter. Klingman & Associates LLC now owns 3,566 shares of the company’s stock worth $334,000 after purchasing an additional 147 shares in the last quarter. National Pension Service increased its holdings in Colgate-Palmolive by 6.7% during the first quarter. National Pension Service now owns 1,974,063 shares of the company’s stock worth $184,970,000 after buying an additional 123,814 shares during the last quarter. OneAscent Investment Solutions LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $288,000. Finally, Kovitz Investment Group Partners LLC lifted its position in shares of Colgate-Palmolive by 0.6% in the first quarter. Kovitz Investment Group Partners LLC now owns 155,725 shares of the company’s stock valued at $14,591,000 after buying an additional 869 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to Evaluate a Stock Before Buying
- Walmart’s NASDAQ Switch Could Change Everything for WMT Stock
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- GameStop Looks Broken: Here’s Why GME Could Crash in 2026
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Market Momentum: 3 Stocks Poised for Major Breakouts
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
